Magnetic Resonance Imaging (MRI) Guided Focal Laser Interstitial Thermal Ablation of Localized Prostate Cancer: A Phase II Clinical Trial
18 Years and older, Male
This phase II trial studies the side effects of magnetic resonance imaging (MRI) guided focal laser ablation and to see how well it works in treating participants with prostate cancer that has not spread to other parts of the body. MRI guided focal laser ablation uses laser fibers under MRI guidance to burn and kill tumors, and may help to improve urinary and rectal continence and erectile function in participants with prostate cancer.
I. To determine the safety and efficacy of MRI guided focal laser ablation of localized low and intermediate risk prostate cancer.
Participants undergo MRI guided focal laser ablation.
After completion of study treatment, participants are followed up at 3 weeks, 3 and 6 months, and 1 and 2 years.